Plasma and cerebrospinal fluid pharmacokinetics of moxifloxacin in a patient with tuberculous meningitis.
about
Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.Randomized pharmacokinetic and pharmacodynamic comparison of fluoroquinolones for tuberculous meningitis.Overton's rule helps to estimate the penetration of anti-infectives into patients' cerebrospinal fluidEffect of genetic variation in UGT1A and ABCB1 on moxifloxacin pharmacokinetics in South African patients with tuberculosis.
P2860
Plasma and cerebrospinal fluid pharmacokinetics of moxifloxacin in a patient with tuberculous meningitis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Plasma and cerebrospinal fluid ...... t with tuberculous meningitis.
@en
Plasma and cerebrospinal fluid ...... t with tuberculous meningitis.
@nl
type
label
Plasma and cerebrospinal fluid ...... t with tuberculous meningitis.
@en
Plasma and cerebrospinal fluid ...... t with tuberculous meningitis.
@nl
prefLabel
Plasma and cerebrospinal fluid ...... t with tuberculous meningitis.
@en
Plasma and cerebrospinal fluid ...... t with tuberculous meningitis.
@nl
P2093
P2860
P356
P1476
Plasma and cerebrospinal fluid ...... nt with tuberculous meningitis
@en
P2093
D van Soolingen
G J Luijckx
J W C Alffenaar
P M de Vries
R van Altena
P2860
P304
P356
10.1128/AAC.01637-07
P407
P577
2008-03-24T00:00:00Z